Tag: CardiAi

CardiAi Inc. launches “BPAro” a Brand New FDA & Health Canada approved Clinically validated 24-hour Ambulatory Blood Pressure Monitoring System with all new features including Bluetooth, Diabetes setting & Auto Interpretation of results

Regulatory Rhythm by 0 comments

CALGARY, AB, July 27, 2022 /PRNewswire/ – CardiAI Inc. is pleased to announce the Global launch & distribution of their brand new 24-hour Ambulatory Blood Pressure monitoring system. BPAro is a compact, portable, German-manufactured, self-monitoring blood pressure device that uses Bluetooth for […]

Continue Reading →